| Name | Title | Contact Details |
|---|---|---|
Bruce Gray |
Chief Information and Digital Officer | Profile |
Ryan Zea |
Director of Emerging Technology | Profile |
Tod Wiederholt |
Director of Infrastructure Technology | Profile |
Tod Wiederholt |
Director, Infrastructure Technology | Profile |
Jill Gunnufson Buh |
Deputy Information System Security Officer | Profile |
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
PharmaForce International is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mid Ohio Radiology is a Powell, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Simulation and Training Environment Laboratory is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cameron Hall Assisted Living is a Canton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.